Transcriptionally active enhancers in human cancer cells.
Katja LidschreiberLisa A JungHenrik von der EmdeKashyap DaveJussi TaipalePatrick CramerMichael LidschreiberPublished in: Molecular systems biology (2021)
The growth of human cancer cells is driven by aberrant enhancer and gene transcription activity. Here, we use transient transcriptome sequencing (TT-seq) to map thousands of transcriptionally active putative enhancers in fourteen human cancer cell lines covering seven types of cancer. These enhancers were associated with cell type-specific gene expression, enriched for genetic variants that predispose to cancer, and included functionally verified enhancers. Enhancer-promoter (E-P) pairing by correlation of transcription activity revealed ~ 40,000 putative E-P pairs, which were depleted for housekeeping genes and enriched for transcription factors, cancer-associated genes, and 3D conformational proximity. The cell type specificity and transcription activity of target genes increased with the number of paired putative enhancers. Our results represent a rich resource for future studies of gene regulation by enhancers and their role in driving cancerous cell growth.
Keyphrases
- transcription factor
- genome wide
- gene expression
- genome wide identification
- papillary thyroid
- endothelial cells
- dna methylation
- single cell
- squamous cell
- induced pluripotent stem cells
- squamous cell carcinoma
- pluripotent stem cells
- lymph node metastasis
- rna seq
- dna binding
- binding protein
- bioinformatics analysis
- childhood cancer
- blood brain barrier
- high density